← Eichor
Study identifier: NCT06925880 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Knee Arthroplasty

Condition: Sarcopenia in Elderly · Frailty at Older Adults · Functional Capacity  ·  Sponsor: Consorci Sanitari del Maresme

PhaseNA
Planned participants262
Who can joinAll sexes, 65 Years to no upper limit
Healthy volunteersNo

About this study

Double-blind randomized placebo-controlled clinical trial with two parallel arms. The main objective is to evaluate the efficacy and safety of creatine supplementation in older adults who have been operated on for total knee arthroplasty and undergoing a usual rehabilitation program. The intervention will consist of daily creatine monohydrate supplementation for 12 weeks. The intervention will start after surgery with a loading dose of 20g/day for 1 week and then continue with a maintenance dose of 5g/day for 11 weeks. Main outcome mesures included muscle mass, muscle strenght, sarcopenia, frailty, functional capacity and physical performance and will be assessed at baseline, 3 and 6 months follow-up.

This description comes directly from the study's public registry record.

Talk to the study team

Jéssica Martínez Rodríguez  ·  0034 937417700  ·  jmartinezro@csdm.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Elisabet PalomeraMataró, Barcelona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06925880